To investigate the mechanism of RFX1 downregulation in CD4+ T cells of SLE patients, we also determined the effect of IL-6-STAT3 signaling on RFX1 expression in CD4+ T cells of SLE patients. This evidence concerns the gene CD4 and systemic lupus erythematosus.